SCHEMBL11337182

SCHEMBL11337182

C=CC(C)CC/C=C(\C)CCC=C(C)C

nearest known ligand 0.57

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.57
ALOX15 P16050 3/20 0.52
MAPT P10636 2/20 0.52
MEN1 O00255 2/20 0.52
CYP3A4 P08684 2/20 0.52
ALDH1A1 P00352 1/20 0.52
UGT1A1 P22309 1/20 0.52
SQLE Q14534 4/20 0.50
FNTA P49354 1/20 0.47
FNTB P49356 1/20 0.47
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25333837 1.00 KMT2A (0.57) KMT2AALOX15MAPTMEN1CYP3A4
SCHEMBL9484275 1.00 KMT2A (0.57) KMT2AALOX15MAPTMEN1CYP3A4
SCHEMBL4623731 1.00 KMT2A (0.57) KMT2AALOX15MAPTMEN1CYP3A4
SCHEMBL11620500 1.00 KMT2A (0.57) KMT2AALOX15MAPTMEN1CYP3A4
SCHEMBL28674581 1.00 KMT2A (0.57) KMT2AALOX15MAPTMEN1CYP3A4
Beta-Citronellene SCHEMBL21872 0.88 ALOX15 (0.50) KMT2AALOX15ALDH1A1
Beta-Citronellene SCHEMBL2456981 0.88 ALOX15 (0.50) KMT2AALOX15ALDH1A1
Beta-Citronellene SCHEMBL7808244 0.88 ALOX15 (0.50) KMT2AALOX15ALDH1A1
SCHEMBL31412791 0.84 HPGD (0.46) KMT2AALOX15MAPTALDH1A1FNTA
SCHEMBL228079 0.84 HPGD (0.46) KMT2AALOX15MAPTALDH1A1FNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695016-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Givaudan SA (CH) 2026-02-18 EP disclosed
US-20250042827-A1 OLEFINS AND METHODS FOR MAKING THE SAME EUAGORE, LLC 2025-02-06 US disclosed
US-12187674-B2 Olefins and methods for making the same Amyris, Inc. (US) 2025-01-07 US disclosed
WO-2024213507-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2024-10-17 WO disclosed
US-20240043356-A1 OLEFINS AND METHODS FOR MAKING THE SAME EUAGORE, LLC 2024-02-08 US disclosed
US-11802100-B2 Olefins and methods for making the same Amyris, Inc. (US) 2023-10-31 US disclosed
US-20230167378-A1 LUBRICATING OIL COMPOSITIONS COMPRISING BIOBASED BASE OILS CHEVRON ORONITE CO (US) 2023-06-01 US disclosed
CN-115867633-A Lubricating oil compositions comprising bio-based base oils 雪佛龙奥伦耐有限责任公司 2023-03-28 CN disclosed
EP-4133040-A1 LUBRICATING OIL COMPOSITIONS COMPRISING BIOBASED BASE OILS Chevron Oronite Company LLC (US) 2023-02-15 EP disclosed
US-20220154092-A1 OLEFINS AND METHODS FOR MAKING THE SAME EUAGORE, LLC 2022-05-19 US disclosed
US-20170121630-A1 HYDRAULIC FLUIDS FROM RENEWABLE ISOPARAFFINS NOVVI LLC 2017-05-04 US disclosed
US-20170009119-A1 DIELECTRIC FLUID AND COOLANT MADE WITH BIOBASED BASE OIL NOVVI LLC 2017-01-12 US disclosed
US-20140221258-A1 BASE OILS AND METHODS FOR MAKING THE SAME Amyris, Inc. (US) 2014-08-07 US disclosed
US-20140148624-A1 OLEFINS AND METHODS FOR MAKING THE SAME Amyris, Inc. (US) 2014-05-29 US disclosed
EP-2697187-A1 OLEFINS AND METHODS FOR MAKING THE SAME Amyris, Inc. (US) 2014-02-19 EP disclosed
EP-2697186-A1 BASE OILS AND METHODS FOR MAKING THE SAME Amyris, Inc. (US) 2014-02-19 EP disclosed
WO-2012141784-A1 BASE OILS AND METHODS FOR MAKING THE SAME Amyris, Inc. (US) 2012-10-18 WO disclosed
WO-2012141783-A1 OLEFINS AND METHODS FOR MAKING THE SAME Amyris, Inc. (US) 2012-10-18 WO disclosed
EP-0029617-A1 Use of tertiary heterocyclic amines as synergists in pesticides; derivatives of cycloamines C.F. Spiess & Sohn GmbH & Co. Chemische Fabrik (DE) 1981-06-03 EP disclosed
US-4116955-A META-CYCLOPHANE AND A TRANS-TERPENOID, SEPARATION OF ISOMERS TEIJIN LIMITED (JP) 1978-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250042827-A1 OLEFINS AND METHODS FOR MAKING THE SAME HSD17B10, DHCR7, HSD17B12 KMT2A 2965/4885ALOX15 34/4885MAPT 3763/4885
US-20240043356-A1 OLEFINS AND METHODS FOR MAKING THE SAME HSD17B10, DHCR7, HSD17B12 KMT2A 2965/4885ALOX15 34/4885MAPT 3763/4885
US-20140221258-A1 BASE OILS AND METHODS FOR MAKING THE SAME OSBP, OSBPL8, FDFT1 KMT2A 3448/4885ALOX15 36/4885MAPT 3935/4885
US-20220154092-A1 OLEFINS AND METHODS FOR MAKING THE SAME HSD17B10, DHCR7, HSD17B12 KMT2A 2865/4885ALOX15 26/4885MAPT 3808/4885
US-11802100-B2 Olefins and methods for making the same HSD17B10, DHCR7, HSD17B12 KMT2A 2865/4885ALOX15 26/4885MAPT 3808/4885
US-20140148624-A1 OLEFINS AND METHODS FOR MAKING THE SAME HSD17B10, DHCR7, HSD17B12 KMT2A 2965/4885ALOX15 34/4885MAPT 3763/4885
US-12187674-B2 Olefins and methods for making the same HSD17B10, DHCR7, HSD17B12 KMT2A 2965/4885ALOX15 34/4885MAPT 3763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.